Administration mode matters for 5‐fluorouracil therapy: Physiologically based pharmacokinetic evidence for avoidance of myelotoxicity by continuous infusion but not intravenous bolus

Documenti analoghi

• Pharmacokinetics of subcutaneous and intravenous bolus doses of morphine in palliative care cancer patients receiving infusion of morphine: A pharmacokinetic substudy of a randomized controlled trial
  di: Eva Gravdahl, et al.
  Pubblicazione: (2025)
• Can a population pharmacokinetics model built on intermittent infusions accurately predict meropenem concentrations in children receiving continuous infusions?
  di: Lucy Cheng, et al.
  Pubblicazione: (2025)
• Physiologically based pharmacokinetic modelling of cefoperazone in paediatrics
  di: Qiushi Wang, et al.
  Pubblicazione: (2024)
• Physiologically based pharmacokinetic modelling predicts altered maternal pharmacokinetics of amitriptyline during pregnancy
  di: Maike Scherf‐Clavel, et al.
  Pubblicazione: (2025)
• External evaluation of intravenous vancomycin population pharmacokinetic models in adults receiving high‐flux intermittent haemodialysis
  di: Cheng Ji, et al.
  Pubblicazione: (2024)